PATENT CLAIM ANALYSIS

Application Number: 16244427
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "451000"]

Abstract:
The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.

Claim (Index 22):
A method of prolonging survival in a human patient afflicted with pancreatic cancer comprising administering to the patient an amount of cysteamine, cystamine, or pharmaceutically acceptable salt thereof in an amount effective to prolong survival of the patient, the amount being less than an amount cytotoxic to the cancer.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14353273', '14332829', '13277942', '15284416', '15771947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7279245969724544
- 35 USC 102 Novelty (BERT): 0.5013818120728304
- Combined Prediction Score: 0.705270318482492
- Mean Citation Score: 249.429072
- Max Citation Score: 254.49219
- Similarity Product: 180.341277296859

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test